CTLP CANTALOUPE, INC.

Nasdaq cantaloupe.com


$ 10.62 $ 0.03 (0.28 %)    

Tuesday, 14-Oct-2025 15:59:59 EDT
QQQ $ 598.50 $ -4.01 (-0.67 %)
DIA $ 463.08 $ 2.03 (0.44 %)
SPY $ 662.74 $ -0.81 (-0.12 %)
TLT $ 90.69 $ 0.29 (0.32 %)
GLD $ 382.95 $ 2.70 (0.71 %)
$ 10.62
$ 10.60
$ 10.52 x 3
$ 10.71 x 5
$ 10.57 - $ 10.63
$ 7.01 - $ 11.36
332,328
na
779.18M
$ 0.91
$ 12.18
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 09-08-2025 06-30-2025 10-K
2 05-08-2025 03-31-2025 10-Q
3 02-06-2025 12-31-2024 10-Q
4 11-07-2024 09-30-2024 10-Q
5 09-10-2024 06-30-2024 10-K
6 05-09-2024 03-31-2024 10-Q
7 02-08-2024 12-31-2023 10-Q
8 11-09-2023 09-30-2023 10-Q
9 09-25-2023 06-30-2023 10-K
10 05-09-2023 03-31-2023 10-Q
11 02-09-2023 12-31-2022 10-Q
12 11-09-2022 09-30-2022 10-Q
13 10-19-2022 06-30-2022 10-K
14 05-06-2022 03-31-2022 10-Q
15 02-04-2022 12-31-2021 10-Q
16 11-05-2021 09-30-2021 10-Q
17 09-03-2021 06-30-2021 10-K
18 05-07-2021 03-31-2021 10-Q
19 02-05-2021 12-31-2020 10-Q
20 11-06-2020 09-30-2020 10-Q
21 09-11-2020 06-30-2020 10-K
22 06-24-2020 03-31-2020 10-Q
23 02-18-2020 12-31-2019 10-Q
24 11-12-2019 09-30-2019 10-Q
25 10-09-2019 06-30-2019 10-K
26 10-09-2019 09-30-2018 10-Q
27 10-09-2019 03-31-2019 10-Q
28 10-09-2019 12-31-2018 10-Q
29 05-10-2018 03-31-2018 10-Q
30 02-09-2018 12-31-2017 10-Q
31 11-09-2017 09-30-2017 10-Q
32 08-23-2017 06-30-2017 10-K
33 05-10-2017 03-31-2017 10-Q
34 02-09-2017 12-31-2016 10-Q
35 11-09-2016 09-30-2016 10-Q
36 09-13-2016 06-30-2016 10-K
37 05-13-2016 03-31-2016 10-Q
38 02-12-2016 12-31-2015 10-Q
39 11-13-2015 09-30-2015 10-Q
40 09-30-2015 06-30-2015 10-K
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 benchmark-downgrades-cantaloupe-to-hold

Benchmark analyst Mark Palmer downgrades Cantaloupe (NASDAQ:CTLP) from Buy to Hold.

 barrington-research-downgrades-cantaloupe-to-underperform

Barrington Research analyst Gary Prestopino downgrades Cantaloupe (NASDAQ:CTLP) from Outperform to Underperform.

 william-blair-downgrades-cantaloupe-to-market-perform

William Blair analyst Cristopher Kennedy downgrades Cantaloupe (NASDAQ:CTLP) from Outperform to Market Perform.

 cantaloupe-shares-resume-trade
Cantaloupe Shares Resume Trade
06/16/2025 13:51:18

 cantaloupe-to-be-acquired-by-365-retail-markets-in-848m-all-cash-deal-at-1120-per-share

Cantaloupe shareholders to receive $11.20 per share in cash, a 34% premium to unaffected stock priceTransaction to accelerate g...

 barrington-research-maintains-outperform-on-cantaloupe-maintains-14-price-target

Barrington Research analyst Gary Prestopino maintains Cantaloupe (NASDAQ:CTLP) with a Outperform and maintains $14 price tar...

 cantaloupe-q3-adj-eps-009-misses-010-estimate-sales-7543m-miss-7983m-estimate

Cantaloupe (NASDAQ:CTLP) reported quarterly earnings of $0.09 per share which missed the analyst consensus estimate of $0.10 by...

 cantaloupe-lowers-fy2025-sales-guidance-from-30800m-32200m-to-30200m-30800m-vs-30990m-est

Cantaloupe (NASDAQ:CTLP) lowers FY2025 sales outlook from $308.00 million-$322.00 million to $302.00 million-$308.00 million vs...

 barrington-research-maintains-outperform-on-cantaloupe-maintains-14-price-target

Barrington Research analyst Gary Prestopino maintains Cantaloupe (NASDAQ:CTLP) with a Outperform and maintains $14 price tar...

 deal-dispatch-boeing-done-with-drones-plus-bp-to-sell-lubricants-7-eleven-parent-nixes-58-billion-bid

From Walgreens' breakup to Forever 21's pending bankruptcy, M&A and drama unfold in this week's edition of Deal...

 benchmark-maintains-buy-on-cantaloupe-raises-price-target-to-13

Benchmark analyst Mark Palmer maintains Cantaloupe (NASDAQ:CTLP) with a Buy and raises the price target from $11 to $13.

 cantaloupe-shares-resumed-trade
Cantaloupe Shares Resumed Trade
02/25/2025 19:19:48

Core News & Articles

-Reuters Citing Sources

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION